COMMUNIQUÉS West-GlobeNewswire

Klox Technologies announces positive top-line results from a pivotal study of Phovia™ for the management of Canine Deep Pyoderma
02/07/2018
DUBLIN, Ireland, July 02, 2018 (GLOBE NEWSWIRE) -- Klox Technologies Limited, a subsidiary of Klox Technologies Inc. (‘KTI’) has announced they have completed a pivotal study of Phovia for the management of Canine Deep [...]
K2M Group Holdings, Inc. to Release Second Quarter of Fiscal Year 2018 Financial Results on August 1, 2018
02/07/2018
LEESBURG, Va., July 02, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional [...]
Teligent, Inc. Announces FDA Approval of Lidocaine and Prilocaine Cream USP, 2.5%/2.5%
02/07/2018
BUENA, N.J., July 02, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]
Wave Life Sciences Receives Positive Opinion for Orphan Drug Designation in the European Union for WVE-210201
02/07/2018
Investigational WVE-210201 in development for treatment of Duchenne muscular dystrophy patients amenable to exon 51 skipping Patients currently enrolling in global Phase 1 clinical trial CAMBRIDGE, Mass., July 02, 2018 [...]
Immutep Submits Investigational New Drug (IND) Application With FDA
02/07/2018
SYDNEY, Australia, July 02, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ:IMMP) (“Immutep” or “the Company”) is pleased to announce that it has submitted its Investigational New Drug (“IND”) application to [...]
Quotient Limited Announces Completion of Senior Secured Notes Offering
02/07/2018
JERSEY, Channel Islands, July 02, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), has completed the offering of up to $120.0 million aggregate principal [...]
PolarityTE Adds Peter Cohen, Former Board Member of the NYSE and Chairman and CEO of Cowen Inc., to the Board of Directors
02/07/2018
SALT LAKE CITY, July 02, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq:COOL) today announced that Peter Cohen will join PolarityTE’s Board of Directors. Mr. Cohen is well known within the investment community having [...]
Medovex Corporation’s DenerveX System Demonstrates Clinical Benefits in Patients Suffering from Low Back Facet Joint Pain
02/07/2018
Review of Real World Cases from Five Independent Sites Across Europe Demonstrated Reduction in Pain Scores and General Improvement of Health Metrics up to 6 Months Following Treatment as Evidenced by VAS BACK , ODI and [...]
SeaSpine Names Dennis L. Cirino Senior Vice President, Spinal Systems
02/07/2018
CARLSBAD, Calif., July 02, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced [...]
Novo Nordisk A/S - Share repurchase programme
02/07/2018
Bagsværd, Denmark, 2 July 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR), [...]
Nuvectra Provides Update on FDA and TÜV SÜD Review of Virtis™ PMA and CE Mark Applications
02/07/2018
PLANO, Texas, July 02, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, today provided an update on its U.S. Food and Drug Administration (FDA) pre-market approval [...]
Conatus Pharmaceuticals’ Pan-caspase Inhibitor Emricasan Improves Survival and Portal Hypertension in a Mouse Model of Cirrhosis
02/07/2018
SAN DIEGO, July 02, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced the publication 1 of results from preclinical studies of its pan-caspase inhibitor emricasan, demonstrating [...]
Transactions under Novozymes’ stock buyback program
02/07/2018
Please read the full announcement in the attached PDF Attachment 2018_41_Stock_Buybackprogram_EN
BrightGuard Installs Free Sunscreen Dispensers at New York City Public Pools and Beaches
02/07/2018
First-of-its-Kind Automated Sunscreen Dispenser Company Teams with Coppertone® and IMPACT Melanoma to Provide Free, High-Quality Sunscreen to Help Reduce NYC’s Risk of Skin Cancer NEW YORK and NEWPORT BEACH, Calif., [...]
RedHill Biopharma Announces Allowance of Two New RHB-104 Patents Ahead of Top-Line Phase III Results for Crohn’s Disease
02/07/2018
RedHill has received Notices of Allowance for two new patents covering RHB-104 in the U.S. and Europe which are expected to be valid until at least 2029, once granted Top-line results from the first Phase III study with [...]
Athenex Announces Pipeline Expansion Initiatives in Conjunction with a Strategic Investment of $100 million by Perceptive Advisors
02/07/2018
Collaboration with Xiangxue Pharmaceutical Expands Portfolio in to TCR-T Immunotherapy In-Licensing of a Biologic Product from Avalon BioMedical Management BUFFALO, N.Y., July 02, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc [...]
PotNetwork Holdings, Inc. Changing Name To Biotech Hemp, Inc. and Moves Forward on Filings In Preparation for Uplisting
02/07/2018
Company to Rapidly Complete FINRA Application, and Form 10 To Become Fully Reporting SEC Issuer FT LAUDERDALE, Fla., July 02, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holdings, Inc. (OTC Pink:POTN) [...]
Mesoblast Enters Into US$50M Financing with Novaquest Capital for Commercial Readiness of Remestemcel-l in the Treatment of Acute Graft Versus Host Disease
02/07/2018
NEW YORK and MELBOURNE, Australia, July 02, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced a US$50 million financing from NovaQuest Capital Management, L.L.C. (NovaQuest) for the [...]
Arrayit Corporation Completes Allergy Testing Pilot Program for One of the Nation’s Largest Retail Chains
02/07/2018
Sunnyvale, July 02, 2018 (GLOBE NEWSWIRE) -- July 2, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces that the company has completed an allergy [...]

Pages